High Prevalence of CTX-M-15-Producing O25b-ST131 Escherichia coli Clone in Bulgarian Hospitals

High Prevalence of CTX-M-15-Producing O25b-ST131 Escherichia coli Clone in Bulgarian Hospitals
复制标题

DOI:
10.1089/mdr.2011.0186
复制
发表时间:
2012-08-01
影响因子:
2.6
通讯作者:
Mitov, Ivan
Mitov, Ivan
中科院分区:
医学4区
文献类型:
--
作者:
Markovska, Rumyana;Schneider, Ines;Mitov, Ivan

文献摘要

被引文献

相似文献

根据欧洲抗菌素耐药性监测系统项目结果,保加利亚已成为超广谱β-内酰胺酶(ESBL)生产者比例急剧增加的欧洲国家之一。这项工作的目的是调查产ESBL大肠埃希菌临床分离株在保加利亚的流行病学,收集从七个临床中心在三个城镇,在两个研究期间:2002-2003年和2006-2009年。对193株产ESBL E.大肠杆菌O25 b-ST 131菌株的随机扩增多态性DNA(RAPD)分析、系统发育分型和筛选。分析药敏结果、ESBL分型及耐药决定因素的可转移性。ESBL分型有TEM-139、SHV-12、CTX-M-3和CTX-M-15 4种,以CTX-M-15为主,占88%。RAPD分型结果显示35个类型,其中A型占优势,占65%的菌株。68%的193株分离株属于O25 b-ST 131克隆,属于系统发育群B2,大多数显示RAPD A型(92%),并在所有参与医院中发现。O25 b-ST 131分离株主要产生CTX-M-15(96%),较少产生SHV-12(n = 3)或TEM-139(n = 2)。总之,本研究首次证实了产高度耐B2 O25 b-ST 131 CTX-M-15大肠杆菌的全国范围传播。coli克隆。
According to the European Antimicrobial Resistance Surveillance System project results, Bulgaria has become one of the European countries with dramatically increasing rates of extended-spectrum beta-lactamase (ESBL) producers. The aim of this work was to investigate the epidemiology of ESBL-producing Escherichia coli clinical isolates in Bulgaria, collected from seven clinical centers in three towns, during two study periods: 2002-2003 and 2006-2009. For 193 ESBL-producing E. coli isolates random amplified polymorphic DNA (RAPD) analyses, phylogenetic typing, and screening for O25b-ST131 isolates were carried out. Antimicrobial susceptibility, ESBL-type and transferability of resistance determinants were analyzed. Four different ESBL-types, namely TEM-139, SHV-12, CTX-M-3, and CTX-M-15 were found. CTX-M-15 dominated, being found in 88% of the isolates. RAPD-typing revealed 35 types, among which type A dominated, comprising 65% of the isolates. Sixty-eight percent of the 193 isolates belonged to the O25b-ST131 clone, to the phylogenetic group B2, mostly showed RAPD-type A (92%) and were found in all participating hospitals. O25b-ST131 isolates predominantly produced CTX-M-15 (96%), and less SHV-12 (n = 3) or TEM-139 (n = 2). In conclusion, this study demonstrated for the first time the country-wide dissemination of a highly resistant B2 O25b-ST131 CTX-M-15 producing E. coli clone in Bulgaria.